West Pharmaceutical Services, Inc. Stock News

EXTON, Pa. , Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Easte...

West Pharmaceutical Services, Inc. (WST, Financial) has announced the upcoming resignation of its Senior Vice President and Chief Technology Officer, Silji Abraham. According to a recent Form 8-K filing with the United States Securities and Exchange Commission, Mr.

EXTON, Pa. , Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with Fox Chase Cancer Center, a part of the Temple University Health System. This award recognizes companies, ind...

EXTON, Pa. , Oct. 7, 2024  /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challenges and trends in packaging and containment. This year, West will highlight its industry expertise through...

EXTON, Pa. , Sept. 5, 2024 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Global Healthcare Conference in London, UK on Wednesday, September 18, 2024, at 9:55 AM BST.

West Pharmaceutical Q2'24 results missed expectations, with lower revenues and EPS missing guidance, impacted by destocking and poor sales in various segments. Management remains optimistic for the back half of the year, with capital investments to support growth, but cash flow concerns and high valuation pose risks. Despite the recent drop in WST share price, the company's high valuation and u...

West Pharmaceutical Services, Inc. (NYSE:WST ) Q2 2024 Earnings Conference Call July 25, 2024 9:00 AM ET Company Participants John Sweeney - Head of IR Eric Green - CEO Bernard Birkett - SVP, Chief Financial and Operations Officer Conference Call Participants Paul Knight - KeyBanc Capital Markets Larry Solow - CJS Securities Justin Bowers - Deutsche Bank Mike Ryskin - Bank of America Matt Larew...

West Pharmaceutical Services cut its annual profit and sales forecast on Thursday, on lower demand for its medical equipment used in making injectable drugs as biotech customers worked through their existing inventories.